woundcarping
GLP-1 Specialist

Here's the PDF of the article.




Sounds like ERP is one step from an exit scam finally.mtomm said:It's not just one issue. It's a long article.

quoted said:A newer discussion around ERP linked R20 kits suggests the issue may be spreading more widely than many buyers assume.
Users described vials that turned cloudy immediately with Hospira BAC, while others from the same broader source stream reportedly remained fine. The explanation circulating was residual TFA salts left behind during finishing, not a failed sequence, not a classic purity issue, but a compatibility problem that only reveals itself during reconstitution.
From the comments:quoted said:The harder truth is this;
A peptide can be chemically correct and still be practically wrong.
And right now, Retatrutide is forcing the grey market to confront something it has largely ignored:
Passing a lab test is not the same as performing properly in solution.
The lab says it’s fine.
The vial says it isn’t.
And right now, the vial is telling the more important story.
quoted said:You’re right that Reta is the ultimate stress test for the grey market. Because it is larger and more chemically modified than Tirzepatide, it has more "arms" (amino acid side chains) that can unfold or clump if the environment isn't perfect.
It exposes "sloppy" finishing—specifically high salt/TFA loads—that simpler peptides might be able to mask.

I feel like there's so much legitimate profit to be made in this space. Why do some vendors insist on cheating people out of pennies instead of seeing the pounds that could be made by establishing themselves as the "goto" vendor for quality. It seems to be an issue with many Chinese companies--not just peptide sellers.RetCurious said:Sounds like ERP is one step from an exit scam finally.

FartfulCodger said:I feel like there's so much legitimate profit to be made in this space. Why do some vendors insist on cheating people out of pennies instead of seeing the pounds that could be made by establishing themselves as the "goto" vendor for quality. It seems to be an issue with many Chinese companies--not just peptide sellers.
And how many newly-announced vendors that we see are just a rebrand of an exit scam vendor?

Isnt there a R15 issue too? Affecting erp and at least 3 other vendors.... only time JEEP told the truth was when they said raws are getting shitty and scarce....Calm Logic said:For quality issues, even Uther has been sucking for some things lately regarding purity and endotoxins, with a record amount of endotoxins for NAD+. Uther had ARA-290 at 86% purity. Low purity for SNAP-8 as well (94%). But Uther has been pretty transparent.
It reminds of the zero peptides situation around December 2024 (before my time) where multiple vendors were affected. More recently, the cloudy reta this year from multiple vendors, possibly due to TFA salts (not just vendor BAC).
SRY had a number of quality concerns last spring/summer, like little black specks in vials. Nexaph had a similar issue with the black specks last May.


I’ll send you some $ to share results w/ me. Dm me if it’s possible.5byfive said:I have Orange top ERP T30 out for endo right now. I don't think it is from the same supply chain as JEEP (although ERP is definitly the same as WBS) and the cap does not have a ridge but the endo problem seems to be growing (or its one of those things that was always there and we are just not seeing it becuse we are looking at it harder).

Well damn. I never ordered from them, but hsd seen people praising them. That one reply regarding the UK refund was all I needed to see. Scum bag BS to me.woundcarping said:Here's the PDF of the article.

BNLFL said:Well damn. I never ordered from them, but hsd seen people praising them. That one reply regarding the UK refund was all I needed to see. Scum bag BS to me.

God, I hope your right !!Raptorrunner said:Not sure who some lady & her AI ghostwriter is but found her article pretty 'meh' overall. If you told me she shills for another market I wouldn't be too surprised.
If you told me she's a government or pharma plant trying to kill off a segment that wouldn't surprise me either.